Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Intravenous proton pump inhibitors.

Danial E Baker1

  • 1College of Pharmacy, Washington State University, Spokane, Washington, USA.

Reviews in Gastroenterological Disorders
|March 8, 2006
PubMed
Summary

Intravenous proton pump inhibitors (PPIs) offer faster gastric acid suppression than oral forms. IV PPIs achieve quicker, more effective acid control and better bioavailability for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prospective Audit and Feedback of Targeted Antimicrobials Use at a Tertiary Care Hospital in the United Arab Emirates.

Antibiotics (Basel, Switzerland)·2025
Same author

Sulopenem Etzadroxil/Probenecid.

Hospital pharmacy·2025
Same author

Axatilimab.

Hospital pharmacy·2025
Same author

Respiratory Syncytial Virus Vaccine (mRNA).

Hospital pharmacy·2024
Same author

Resmetirom.

Hospital pharmacy·2024
Same author

Cefepime/Enmetazobactam.

Hospital pharmacy·2024

Area of Science:

  • Pharmacology
  • Gastroenterology
  • Drug Delivery Systems

Background:

  • Proton pump inhibitors (PPIs) are crucial for managing acid-related gastrointestinal disorders.
  • Traditional oral PPI administration requires several days to achieve peak gastric acid suppression.
  • Intravenous (IV) administration presents an alternative route for PPI delivery.

Purpose of the Study:

  • To compare the efficacy and pharmacokinetic profiles of intravenous (IV) versus oral administration of proton pump inhibitors (PPIs).
  • To highlight the advantages of IV PPIs in achieving rapid and sustained gastric acid suppression.
  • To differentiate between available IV PPI formulations in the United States.

Main Methods:

  • Comparative analysis of pharmacokinetic data for IV and oral PPI administration.
  • Review of clinical studies assessing the onset and duration of gastric acid suppression.
  • Evaluation of formulation-specific characteristics of IV esomeprazole, lansoprazole, and pantoprazole.

Main Results:

  • IV PPI administration achieves peak gastric acid suppression within hours, significantly faster than oral routes.
  • IV PPIs result in intragastric pH closer to neutral compared to oral administration.
  • Available IV PPIs (esomeprazole, lansoprazole, pantoprazole) differ in their ability to reach and maintain specific gastric pH levels and ease of use.

Conclusions:

  • IV PPI administration provides a faster onset and superior gastric acid suppression compared to oral routes.
  • The choice of IV PPI depends on specific clinical indications, desired pH control, and formulation convenience.
  • IV PPIs represent a valuable therapeutic option for rapid acid control in critical care and post-operative settings.

Related Experiment Videos